Roland Diggelmann, Michael Heuer
Roland Diggelmann will be stepping down as CEO of Roche Diagnostics, effective Sept. 30, to pursue his career elsewhere. Michael Heuer, Roche Diagnostics' region head for Europe, the Middle East, Africa, and Latin America, will step in as interim CEO of Roche's diagnostics division and will become a member of the corporate executive committee. He was previously with Boehringer Mannheim, which Roche acquired in 1998. Heuer holds a PhD in chemistry from the University of Kiel in Germany.
Elaine Lyon
Elaine Lyon has joined the HudsonAlpha Institute for Biotechnology as director of the HudsonAlpha Clinical Services Lab. Lyon comes to HudsonAlpha from the University of Utah, where she served as medical director for molecular genetics, genomics, and pharmacogenetics at ARUP Laboratories. She also held a faculty position at the University of Utah School of Medicine. She holds a PhD in medical genetics from the University of Alabama at Birmingham, and completed a fellowship in clinical molecular genetics at the University of Utah. She has served as president of the Association for Molecular Pathology and is a member of the American College of Medical Genetics and Genomics.
Angeline McCabe
Veracyte has named Angeline McCabe as its VP of investor relations and corporate communications, effective immediately. McCabe had been VP of investor relations at WellCare Health Plans, and before that, she held investor relations and corporate communications positions at Health Net and Valeant Pharmaceuticals.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.